Jeryl Lynn Strain Live Attenuated Mumps Virus Vaccine
- 1 January 1968
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 203 (1) , 9-13
- https://doi.org/10.1001/jama.1968.03140010011002
Abstract
The influence of age, virus dose, lot, and γ-globulin administration on serologic and clinical responses to Jeryl Lynn strain live attenuated mumps virus vaccine was studied. Fever or other clinical reaction referable to the vaccine did not develop in childen given vaccine subcutaneously or by jet gun. Mumps antibody of maternal origin suppressed the serologic response to the vaccine. Replicate lots of vaccine gave equally acceptable performance in children. Three hundred seventeen tissue culture doses of mumps vaccine virus were sufficient to immunize. Up to 100 units of mumps neutralizing antibody in human immune globulin coadministered with vaccine but given into the opposite arm did not suppress serologic response to the vaccine. The vaccine was stable for at least one year in dried form and for at least eight hours at 4 C following rehydration.This publication has 8 references indexed in Scilit:
- Comparison of Neutralization and Hemagglutination-Inhibition Techniques for Measuring Mumps AntibodyExperimental Biology and Medicine, 1967
- Live, Attenuated Mumps-Virus VaccineNew England Journal of Medicine, 1967
- Live, Attenuated Mumps-Virus VaccineNew England Journal of Medicine, 1967
- Live Attenuated Mumps Virus Vaccine. 1. Vaccine DevelopmentExperimental Biology and Medicine, 1966
- Advances in control of viral infections by nonspecific measures and by vaccines, with special reference to live mumps and rubella virus vaccinesClinical Pharmacology & Therapeutics, 1966
- Studies of Live Attenuated Measles Virus Vaccine in Man: II. Appraisal of EfficacyAmerican Journal of Public Health and the Nations Health, 1962
- Studies of Live Attenuated Measles Virus Vaccine in Man: I. Clinical AspectsAmerican Journal of Public Health and the Nations Health, 1962
- Studies on an Attenuated Measles-Virus VaccineNew England Journal of Medicine, 1960